BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.95M | 42.35M | 46.54M | 46.95M | 48.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.95M | 42.35M | 46.54M | 46.95M | 48.87M |
| Cost of Revenue | 33.59M | 34.27M | 35.84M | 37.38M | 39.73M |
| Gross Profit | 6.35M | 8.07M | 10.70M | 9.58M | 9.14M |
| SG&A Expenses | 10.82M | 10.36M | 10.57M | 10.86M | 11.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.42M | 44.63M | 46.41M | 48.24M | 50.76M |
| Operating Income | -4.47M | -2.29M | 126.00K | -1.28M | -1.90M |
| Income Before Tax | -3.72M | -1.54M | 784.70K | -698.20K | -1.29M |
| Income Tax Expenses | 452.50K | -309.30K | 331.50K | -76.50K | -238.40K |
| Earnings from Continuing Operations | -4.17 | -1.24 | 0.45 | -0.62 | -1.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.17M | -1.24M | 453.20K | -621.70K | -1.05M |
| EBIT | -4.47M | -2.29M | 126.00K | -1.28M | -1.90M |
| EBITDA | -2.25M | -40.30K | 2.42M | 1.03M | 474.10K |
| EPS Basic | -4.66 | -1.38 | 0.51 | -0.70 | -1.17 |
| Normalized Basic EPS | -2.60 | -1.08 | 0.55 | -0.49 | -0.90 |
| EPS Diluted | -4.66 | -1.38 | 0.50 | -0.70 | -1.18 |
| Normalized Diluted EPS | -2.60 | -1.08 | 0.55 | -0.49 | -0.90 |
| Average Basic Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Average Diluted Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Dividend Per Share | -- | 0.50 | 0.50 | 0.50 | 0.50 |
| Payout Ratio | -- | 0.00% | 0.00% | -71.93% | -42.66% |